XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
License revenue $ 0 $ 250
Research and development 9,063 6,893
General and administrative 5,796 6,202
Restructuring costs (Note 8) 0 225
Total operating expenses 14,859 13,320
Loss from operations (14,859) (13,070)
Other (expense) income:    
Interest expense (12) (15)
Other income, net 433 785
Total other income, net 421 770
Net loss (14,438) (12,300)
Net loss available to common stockholders - basic $ (14,438) $ (12,316)
Loss per common share:    
Basic net loss per common share [1] $ (10.19) $ (27.01)
Diluted net loss per common share [1] $ (10.19) $ (27.01)
Weighted average shares used in computing loss per common share:    
Weighted average shares used in calculating basic loss per common share [1] 1,416,471 456,014
Weighted average shares used in calculating diluted loss per common share [1] 1,416,471 456,014
[1]

(*) Basic and diluted loss per common share and basic and diluted weighted average share used in computing basic and diluted loss per common share for the year ended December 31, 2023 has been adjusted to reflect the 1-for-15 reverse stock split effected on April 5, 2024.